Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroOne Medical Technologies (NMTC)
NASDAQ:NMTC
RESEARCH TOOLSreports
NeuroOne Medical Technologies (NMTC) Stock Price & Analysis
109 Followers
NMTC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $2.00
Previous Close$0.95
Volume65.36K
Average Volume (3M)140.17K
Market Cap
$26.45M
Enterprise Value$23.79M
Total Cash (Recent Filing)$2.68M
Total Debt (Recent Filing)$20.98K
Price to Earnings (P/E)―
Beta-0.33
Next Earnings
Aug 09, 2024EPS Estimate
-$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding27,515,921
10 Day Avg. Volume146,702
30 Day Avg. Volume140,169
Standard Deviation0.31
R-Squared0.03
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)5.19
Price to Sales (P/S)-31.53
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.45
Enterprise Value/Gross Profit52.11
Enterprise Value/Ebitda-1.79
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NeuroOne Medical Technologies News
Ownership Overview
17.47% Insiders
4.04% Mutual Funds
9.06% Other Institutional Investors
69.43% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NMTC FAQ
What was NeuroOne Medical Technologies’s price range in the past 12 months?
NeuroOne Medical Technologies lowest stock price was $0.65 and its highest was $2.00 in the past 12 months.
What is NeuroOne Medical Technologies’s market cap?
Currently, no data Available
When is NeuroOne Medical Technologies’s upcoming earnings report date?
NeuroOne Medical Technologies’s upcoming earnings report date is Aug 09, 2024 which is in 23 days.
How were NeuroOne Medical Technologies’s earnings last quarter?
NeuroOne Medical Technologies released its earnings results on May 14, 2024. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.09 by -$0.02.
Is NeuroOne Medical Technologies overvalued?
According to Wall Street analysts NeuroOne Medical Technologies’s price is currently Overvalued.
Does NeuroOne Medical Technologies pay dividends?
NeuroOne Medical Technologies does not currently pay dividends.
What is NeuroOne Medical Technologies’s EPS estimate?
NeuroOne Medical Technologies’s EPS estimate is -$0.09.
How many shares outstanding does NeuroOne Medical Technologies have?
NeuroOne Medical Technologies has 27,842,102 shares outstanding.
What happened to NeuroOne Medical Technologies’s price movement after its last earnings report?
NeuroOne Medical Technologies reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.09. Following the earnings report the stock price went down -7.018%.
Which hedge fund is a major shareholder of NeuroOne Medical Technologies?
Currently, no hedge funds are holding shares in NMTC
---
NeuroOne Medical Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
NMTC Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $24.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 8.6%
Last 30 Days ▼ 8.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.37%
12-Months-Change
Fundamentals
Return on Equity
-272.79%
Trailing 12-Months
Asset Growth
-25.12%
Trailing 12-Months
Company Description
NeuroOne Medical Technologies
NeuroOne Medical Technologies Corp. operates as a medical technology company. It focuses on development and commercialization of thin film electrode technology for cEEG and sEEG recording, brain stimulation and ablation solutions for patients suffering from brain related disorders. The company was founded on August 20, 2009 and is headquartered in Minnetonka, MN.
---
NMTC Earnings Call
Q2 2024
0:00 / 0:00
---
NMTC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering NMTC
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-11.38%
reiterated a buy rating 5 months ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -11.38% per trade.
---